Sigma-Aldrich offers raw materials with pedigree; P&G targets 5,700 non-manufacturing jobs;

> Sigma-Aldrich ($SIAL) says it is responding to higher regulatory scrutiny that its clients face by releasing 25 new raw materials to its portfolio that feature regulatory support documentation for every lot. Release

> Boehringer Ingelheim and BaroFold have struck a non-exclusive technology and commercial license option agreement in which Boehringer will acquire a laboratory-scale reactor of BaroFold's Pressure Enabled Manufacturing Technology that can also be qualified for GMP use. Release

> Chemical distributor and supply chain services provider Doe & Ingalls has received a distilled spirits plant permit, which allows the company to warehouse and ship tax-free ethyl alcohol (ethanol). Doe & Ingalls will serve its customers through its three bonded service centers in California, North Carolina and Maryland. Item

> HumanZyme will provide HumanKine growth factors and cytokines to PacificGMP to manufacture recombinant human proteins intended for human clinical use. Item

And Finally... Procter & Gamble ($PG) will whack 5,700 non-manufacturing jobs to save money but expects to increase its manufacturing production 5%. Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.